Skip to main content

Table 2 Discharge medications

From: Chemotherapy and adverse cardiovascular events in colorectal cancer patients undergoing surgical resection

Characteristics Total (n = 412) Chemotherapy (n = 200) No chemotherapy (n = 212) P value
Aspirin (n, %) 15 (14.1) 20 (10.0) 38 (17.9) 0.021
Thienopyridines 20 (4.9) 6 (3.0) 14 (6.6) 0.089
Anti-coagulant 9 (2.2) 5 (2.5) 4 (1.9) 0.670
Beta-blocker 101 (24.5) 44 (22.0) 57 (26.9) 0.249
ACE-I/ARB 117 (28.4) 47 (23.5) 70 (33.0) 0.032
Statin 173 (42.0) 75 (37.5) 98 (46.2) 0.073
Metformin 74 (18.0) 33 (16.5) 41 (19.3) 0.453
Sulphonylurea 40 (9.7) 21 (10.5) 19 (9.0) 0.598
DPP-4 inhibitors 9 (2.2) 6 (3.0) 3 (1.4) 0.271
Insulin 15 (3.6) 4 (2.0) 11 (5.2) 0.084
  1. ACE-I angiotensin-converting enzyme inhibitors; ARB angiotensin II receptor blockers; DPP-4 dipeptidyl peptidase-4